Osteosarcoma  >>  figitumumab (CP-751,871)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
figitumumab (CP-751,871) / Novartis
NCT00560235 / 2007-004486-17: Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors

Checkmark P2 data
Oct 2011 - Oct 2011: P2 data
Completed
1/2
138
US, Canada, Europe, RoW
CP-751,871
Pfizer
Ewing's Sarcoma Family of Tumors
03/10
10/12

Download Options